Natixis Portfolio holdings
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$542M |
| 2 |
Apple
AAPL
|
+$491M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$304M |
| 5 |
Amazon
AMZN
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$631M |
| 2 |
Prologis
PLD
|
+$102M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$100M |
| 4 |
Cigna
CI
|
+$81.6M |
| 5 |
Procter & Gamble
PG
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.25% |
| 2 | Consumer Discretionary | 9.63% |
| 3 | Financials | 8.45% |
| 4 | Healthcare | 7.42% |
| 5 | Communication Services | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
676
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $288K | ﹤0.01% |
+181,366
| New | +$269K |
|
|
ENV
677
DELISTED
ENVESTNET, INC.
ENV
| $276K | ﹤0.01% |
4,767
+544
| +13% | +$28.4K |
|
678
Brookfield
BN
$102B
| $275K | ﹤0.01% |
+9,837
| New | +$265K |
|
679
TC Energy
TRP
$73.5B
| $270K | ﹤0.01% |
+6,725
| New | +$265K |
|
|
DSL
680
DoubleLine Income Solutions Fund
DSL
$1.21B
| $270K | ﹤0.01% |
21,227
+77
| +0.4% | +$967 |
|
681
Globalstar
GSAT
$10.2B
| $268K | ﹤0.01% |
+12,174
| New | +$295K |
|
682
Arthur J. Gallagher & Co
AJG
$63.7B
| $266K | ﹤0.01% |
1,065
-46,360
| -98% | -$11.1M |
|
683
Rhythm Pharmaceuticals
RYTM
$7B
| $262K | ﹤0.01% |
6,050
-74,450
| -92% | -$3.26M |
|
684
Martin Marietta Materials
MLM
$33.6B
| $260K | ﹤0.01% |
423
-3,117
| -88% | -$1.7M |
|
|
ITCI
685
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $258K | ﹤0.01% |
3,733
+2,329
| +166% | +$160K |
|
686
EnerSys
ENS
$6.95B
| $257K | ﹤0.01% |
2,724
-555
| -17% | -$52.2K |
|
687
iShares MSCI USA Value Factor ETF
VLUE
$9.4B
| $256K | ﹤0.01% |
2,361
-1,128
| -32% | -$115K |
|
688
Aurinia Pharmaceuticals
AUPH
$1.97B
| $254K | ﹤0.01% |
50,717
-27,897
| -35% | -$189K |
|
689
Dover
DOV
$27.2B
| $252K | ﹤0.01% |
1,425
+1,365
| +2,275% | +$220K |
|
690
Vanguard Value ETF
VTV
$189B
| $249K | ﹤0.01% |
1,530
-732
| -32% | -$113K |
|
691
Century Communities
CCS
$2B
| $247K | ﹤0.01% |
+2,564
| New | +$225K |
|
692
ASML
ASML
$675B
| $238K | ﹤0.01% |
245
-733
| -75% | -$650K |
|
693
Sixth Street Specialty
TSLX
$1.59B
| $237K | ﹤0.01% |
11,060
-77
| -0.7% | -$1.65K |
|
694
iShares MSCI EAFE ETF
EFA
$76.4B
| $237K | ﹤0.01% |
+2,963
| New | +$227K |
|
695
Goldman Sachs BDC
GSBD
$975M
| $235K | ﹤0.01% |
15,625
| – | – |
|
696
IDEX
IEX
$16.5B
| $230K | ﹤0.01% |
943
+830
| +735% | +$187K |
|
697
MetLife
MET
$61B
| $224K | ﹤0.01% |
+3,025
| New | +$211K |
|
698
PennantPark Floating Rate Capital
PFLT
$681M
| $220K | ﹤0.01% |
19,076
| – | – |
|
699
Neurocrine Biosciences
NBIX
$17.7B
| $218K | ﹤0.01% |
1,581
-323
| -17% | -$44.1K |
|
700
NiSource
NI
$22.4B
| $218K | ﹤0.01% |
+7,883
| New | +$207K |
|
Similar funds
Natixis's Q1 2024 Portfolio in Review
As of Q1 2024, Natixis held 1,285 positions worth $19.2B, up 40% from $13.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Natixis deployed $3.46B of net new capital in Q1 2024, opening 260 new positions and adding to 345 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 2,100,100 shares worth $442M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $631M trimmed.
- Natixis's largest Q1 2024 buy was iShares Russell 2000 ETF: 2,100,100 shares worth $442M.
- Natixis added most to Microsoft in Q1 2024, an estimated $542M increase.
- Natixis's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $631M.
- Natixis fully exited Splunk Inc in Q1 2024, selling an estimated $68.7M.
- Natixis's ten largest holdings make up 39% of its $19.2B portfolio in Q1 2024.
- Natixis opened 260 new positions and closed 287 in Q1 2024.
- Natixis's portfolio value rose 40% quarter-over-quarter to $19.2B.
Based on Natixis's 13F filing for Q1 2024, filed 13 May 2024.